Cargando…

Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases

Accumulating data shows that oxidative stress plays a crucial role in neurodegenerative disorders. The literature data indicate that in vivo or postmortem cerebrospinal fluid and brain tissue levels of F(2)-isoprostanes (F(2)-IsoPs) especially F(4)-neuroprotanes (F(4)-NPs) are significantly increase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Elżbieta, Morel, Agnieszka, Saso, Luciano, Saluk, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020162/ https://www.ncbi.nlm.nih.gov/pubmed/24868314 http://dx.doi.org/10.1155/2014/572491

Ejemplares similares

Snapshot situation of oxidative degradation of the nervous system, kidney, and adrenal glands biomarkers-neuroprostane and dihomo-isoprostanes-urinary biomarkers from infancy to elderly adults
por: García-Flores, Libia Alejandra, et al.
Publicado: (2017)

Analytical Variables Affecting Analysis of F(2)-Isoprostanes and F(4)-Neuroprostanes in Human Cerebrospinal Fluid by Gas Chromatography/Mass Spectrometry
por: Yen, Hsiu-Chuan, et al.
Publicado: (2013)

The Level of Isoprostanes as a Non-invasive Marker for in vivo Lipid Peroxidation in Secondary Progressive Multiple Sclerosis
por: Miller, Elżbieta, et al.
Publicado: (2011)

Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
por: Singh, Anju, et al.
Publicado: (2019)

Isoprostanes-Biomarkers of Lipid Peroxidation: Their Utility in Evaluating Oxidative Stress and Analysis
por: Janicka, Monika, et al.
Publicado: (2010)

Decreased Fatty Acid Transporter FABP1 and Increased Isoprostanes and Neuroprostanes in the Human Term Placenta: Implications for Inflammation and Birth Weight in Maternal Pre-Gestational Obesity
por: Belcastro, Livia, et al.
Publicado: (2021)

Relationship between the Increased Haemostatic Properties of Blood Platelets and Oxidative Stress Level in Multiple Sclerosis Patients with the Secondary Progressive Stage
por: Morel, Agnieszka, et al.
Publicado: (2015)

F(4)-Neuroprostane Effects on Human Sperm
por: Moretti, Elena, et al.
Publicado: (2023)

CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis
por: Mir, Fozia, et al.
Publicado: (2014)

Isoprostanes in wastewater as biomarkers of oxidative stress during COVID-19 pandemic
por: Bowers, Isaac, et al.
Publicado: (2021)

F(4)-Neuroprostanes: A Role in Sperm Capacitation
por: Signorini, Cinzia, et al.
Publicado: (2021)

Circulating 4-F(4t)-Neuroprostane and 10-F(4t)-Neuroprostane Are Related to MECP2 Gene Mutation and Natural History in Rett Syndrome
por: Signorini, Cinzia, et al.
Publicado: (2021)

The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target
por: Basu, Samar
Publicado: (2007)

The GPR17 Receptor—A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)

Isoprostanes in Veterinary Medicine: Beyond a Biomarker
por: Putman, Ashley K., et al.
Publicado: (2021)

Relationship of urinary isoprostanes to prostate cancer occurence
por: Brys, Magdalena, et al.
Publicado: (2012)

Oxidative Stress Biomarkers: Establishment of Reference Values for Isoprostanes, AOPP, and NPBI in Cord Blood
por: Longini, Mariangela, et al.
Publicado: (2017)

The increased level of COX-dependent arachidonic acid metabolism in blood platelets from secondary progressive multiple sclerosis patients
por: Morel, Agnieszka, et al.
Publicado: (2016)

Classifying oxidative stress by F(2)-Isoprostane levels in human disease: The re-imagining of a biomarker()
por: Milne, Ginger L.
Publicado: (2017)

Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis
por: Miller, Elżbieta, et al.
Publicado: (2018)

Platelet function and Isoprostane biology. Should Isoprostanes be the newest member of the Orphan-ligand family?
por: Ting, Harold J, et al.
Publicado: (2010)

Dynamics of urinary oxidative stress biomarkers: 8-hydroxy-2'-deoxyguanosine and 8-isoprostane in uterine leiomyomas
por: Asare, George Awuku, et al.
Publicado: (2016)

Circulating Serum VEGF, IGF-1 and MMP-9 and Expression of Their Genes as Potential Prognostic Markers of Recovery in Post-Stroke Rehabilitation—A Prospective Observational Study
por: Włodarczyk, Lidia, et al.
Publicado: (2023)

Pharmaceutical and Pharmacological Aspects of Modulation of Oxidative Stress 2020
por: Saso, Luciano, et al.
Publicado: (2022)

Unusual Bioactive Compounds with Antioxidant Properties in Adjuvant Therapy Supporting Cognition Impairment in Age-Related Neurodegenerative Disorders
por: Cichon, Natalia, et al.
Publicado: (2021)

Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients
por: Morel, Agnieszka, et al.
Publicado: (2017)

Editorial: Redox-signaling in neurodegenerative diseases: biomarkers, targets, and therapies
por: Carvalho, Andreia N., et al.
Publicado: (2023)

8-Isoprostane: A salivary oxidative stress biomarker for oral submucous fibrosis and oral squamous cell carcinoma
por: Meera, S, et al.
Publicado: (2020)

Oxidative Damage of Blood Platelets Correlates with the Degree of Psychophysical Disability in Secondary Progressive Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)

Oxidative stress in neurodegenerative diseases☆
por: Chen, Xueping, et al.
Publicado: (2012)

Oxidative Stress in Neurodegenerative Diseases
por: Niedzielska, Ewa, et al.
Publicado: (2015)

Oxidative stress response in children undergoing cardiac surgery: Utility of the clearance of isoprostanes
por: Hadley, Stephanie, et al.
Publicado: (2021)

F(2)-Isoprostanes as Novel Biomarkers for Type 2 Diabetes: a Review
por: Kaviarasan, Subramanian, et al.
Publicado: (2009)

Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
por: Coviello, Caterina, et al.
Publicado: (2020)

The Role of Oxidative Stress in Neurodegenerative Diseases
por: Kim, Geon Ha, et al.
Publicado: (2015)

Classifying oxidative stress by F(2)-isoprostane levels across human diseases: A meta-analysis
por: van 't Erve, Thomas J., et al.
Publicado: (2017)

Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing–Remitting from Secondary Progressive Multiple Sclerosis. A Review
por: Pietrasik, Sylwia, et al.
Publicado: (2021)

Isoprostanes as Biomarker for White Matter Injury in Extremely Preterm Infants
por: Coviello, Caterina, et al.
Publicado: (2021)

From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis
por: Thatcher, Thomas H., et al.
Publicado: (2022)

Biomarkers of Angiogenesis and Neuroplasticity as Promising Clinical Tools for Stroke Recovery Evaluation
por: Wlodarczyk, Lidia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qj56jmjflakouo18auj0jcp7v9